prmavirtual™
Real-time Business Solutions for your Pricing & Reimbursement
and Market Access needs

Example prmavirtual™ work streams with indicative unit requirements

Units

• Preliminary discussion of EU pricing and reimbursement environment

• Discussion of pricing and reimbursement drivers and environment for a therapeutic indication

• Critique of existing pricing and reimbursement strategy

• Strategic assessment of a value proposition for a Primary Care product and action steps

• Top-line review of existing materials, ‘red flag’ risk analysis

• Preliminary PRMA situation analysis for a therapeutic area (e.g. prices, reimbursement status of competition, HTAs)

• Input into the most appropriate health economic endpoints for a Phase III trial

• Preliminary pricing and reimbursement risk assessment for a potential in-licensing opportunity

• Reverse due diligence/pricing and reimbursement audit of potential licensor

• Discussion of partners’ pricing and reimbursement modelling and negotiations, review of supporting materials and modelling, gap analysis, recommendations

• Detailed review of existing P&R and Health Outcomes materials; full gap analysis and recommendations for further work

• Assessment of current Risk Sharing Agreements and implications for Phase III design

• PRO strategy development and instrument selection

• Epidemiological literature review of a disease and potential market sizing based on reimbursement restrictions

• Detailed PRMA analysis for a product in development